NO20056055L - Fluorescein-labelled peptides - Google Patents
Fluorescein-labelled peptidesInfo
- Publication number
- NO20056055L NO20056055L NO20056055A NO20056055A NO20056055L NO 20056055 L NO20056055 L NO 20056055L NO 20056055 A NO20056055 A NO 20056055A NO 20056055 A NO20056055 A NO 20056055A NO 20056055 L NO20056055 L NO 20056055L
- Authority
- NO
- Norway
- Prior art keywords
- fluorescein
- labeled peptides
- angiogenesis
- optical imaging
- relates
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000033115 angiogenesis Effects 0.000 abstract 2
- 238000012634 optical imaging Methods 0.000 abstract 2
- 239000002872 contrast media Substances 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70546—Integrin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Oppfinnelsen gjelder nye, peptidbaserte forbindelser og deres bruk i diagnostisk optisk avbilding. Mer spesifikt er oppfmnelsen relatert til bruk av slike peptidbaserte forbindelser som målvektorer som binder seg til reseptorer assosiert med angiogenese. Forbindelsene er merket med fiuorescein og kan brukes som konfrastmidler ved optisk avbilding i diagnostikk av angiogeneserelaterte sykdommer.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20056055A NO332926B1 (no) | 2003-07-08 | 2005-12-19 | Peptidbaserte forbindelser, farmasoytiske sammensetninger omfattende slike, fremgangsmate for fremstilling og anvendelse |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20033115A NO20033115D0 (no) | 2003-07-08 | 2003-07-08 | Peptid-baserte forbindelser |
| PCT/NO2004/000208 WO2005003166A1 (en) | 2003-07-08 | 2004-07-07 | Fluorescein-labelled peptides |
| NO20056055A NO332926B1 (no) | 2003-07-08 | 2005-12-19 | Peptidbaserte forbindelser, farmasoytiske sammensetninger omfattende slike, fremgangsmate for fremstilling og anvendelse |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20056055L true NO20056055L (no) | 2006-02-13 |
| NO332926B1 NO332926B1 (no) | 2013-02-04 |
Family
ID=27800789
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20033115A NO20033115D0 (no) | 2003-07-08 | 2003-07-08 | Peptid-baserte forbindelser |
| NO20056055A NO332926B1 (no) | 2003-07-08 | 2005-12-19 | Peptidbaserte forbindelser, farmasoytiske sammensetninger omfattende slike, fremgangsmate for fremstilling og anvendelse |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20033115A NO20033115D0 (no) | 2003-07-08 | 2003-07-08 | Peptid-baserte forbindelser |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7608243B2 (no) |
| EP (1) | EP1639004B1 (no) |
| JP (1) | JP4993463B2 (no) |
| CN (1) | CN1820025A (no) |
| AT (1) | ATE500271T1 (no) |
| DE (1) | DE602004031617D1 (no) |
| ES (1) | ES2361670T3 (no) |
| NO (2) | NO20033115D0 (no) |
| WO (1) | WO2005003166A1 (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2405469C (en) * | 2000-04-12 | 2012-03-20 | Amersham Health As | Integrin binding peptide derivatives |
| BRPI0210886B8 (pt) * | 2001-07-10 | 2021-05-25 | Amersham Health As | composto, composição farmacêutica, uso de um composto, e, métodos de geração de imagens, de monitoração do efeito do tratamento de um corpo humano ou animal com uma droga para combater uma condição associada com câncer e de tratamento de câncer ou de uma doença relacionada em um corpo humano ou animal |
| NO20034350D0 (no) * | 2003-09-29 | 2003-09-29 | Amersham Health As | Optisk avbilding av kolorektal kreft |
| NO20035683D0 (no) * | 2003-12-18 | 2003-12-18 | Amersham Health As | Optisk avbildning av prostatakreft |
| NO20035681D0 (no) * | 2003-12-18 | 2003-12-18 | Amersham Health As | Optisk avbildning av lungekreft |
| RU2393167C2 (ru) * | 2004-06-16 | 2010-06-27 | Джи-И Хелткер АС | Пептидные соединения |
| JP5280682B2 (ja) * | 2004-06-16 | 2013-09-04 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | ペプチド系化合物 |
| DE602005025911D1 (de) * | 2004-11-22 | 2011-02-24 | Ge Healthcare As | Kontrastmittel für eine extrazelluläre matrix |
| GB0428012D0 (en) | 2004-12-22 | 2005-01-26 | Hammersmith Imanet Ltd | Radiolabelling methods |
| EP1833512A1 (en) * | 2005-01-06 | 2007-09-19 | GE Healthcare AS | Optical imaging |
| EP2299277B1 (en) | 2009-09-17 | 2015-10-21 | F. Hoffmann-La Roche AG | Analysis system for analysing biological samples, methods and computer program product |
| PL238871B1 (pl) * | 2018-02-13 | 2021-10-18 | Univ Gdanski | Peptydomimetyk oraz jego zastosowanie jako środek fluorescencyjny in vitro |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6331289B1 (en) * | 1996-10-28 | 2001-12-18 | Nycomed Imaging As | Targeted diagnostic/therapeutic agents having more than one different vectors |
| DE19808591C2 (de) * | 1998-02-28 | 2000-02-03 | Univ Leipzig | Standardisierter durchflußzytometrischer Vollblutassay |
| CA2405469C (en) | 2000-04-12 | 2012-03-20 | Amersham Health As | Integrin binding peptide derivatives |
| NO20004795D0 (no) * | 2000-09-26 | 2000-09-26 | Nycomed Imaging As | Peptidbaserte forbindelser |
| BRPI0210886B8 (pt) * | 2001-07-10 | 2021-05-25 | Amersham Health As | composto, composição farmacêutica, uso de um composto, e, métodos de geração de imagens, de monitoração do efeito do tratamento de um corpo humano ou animal com uma droga para combater uma condição associada com câncer e de tratamento de câncer ou de uma doença relacionada em um corpo humano ou animal |
| GB0206750D0 (en) * | 2002-03-22 | 2002-05-01 | Amersham Plc | Radiofluorination methods |
| GB0317815D0 (en) * | 2003-07-30 | 2003-09-03 | Amersham Health As | Imaging agents |
-
2003
- 2003-07-08 NO NO20033115A patent/NO20033115D0/no unknown
-
2004
- 2004-07-07 EP EP04748784A patent/EP1639004B1/en not_active Expired - Lifetime
- 2004-07-07 CN CN200480019515.0A patent/CN1820025A/zh active Pending
- 2004-07-07 DE DE602004031617T patent/DE602004031617D1/de not_active Expired - Lifetime
- 2004-07-07 ES ES04748784T patent/ES2361670T3/es not_active Expired - Lifetime
- 2004-07-07 AT AT04748784T patent/ATE500271T1/de not_active IP Right Cessation
- 2004-07-07 WO PCT/NO2004/000208 patent/WO2005003166A1/en not_active Ceased
- 2004-07-07 JP JP2006518573A patent/JP4993463B2/ja not_active Expired - Fee Related
- 2004-07-07 US US10/560,062 patent/US7608243B2/en not_active Expired - Fee Related
-
2005
- 2005-12-19 NO NO20056055A patent/NO332926B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2361670T3 (es) | 2011-06-21 |
| ATE500271T1 (de) | 2011-03-15 |
| US7608243B2 (en) | 2009-10-27 |
| US20070183977A1 (en) | 2007-08-09 |
| NO20033115D0 (no) | 2003-07-08 |
| EP1639004A1 (en) | 2006-03-29 |
| JP4993463B2 (ja) | 2012-08-08 |
| DE602004031617D1 (de) | 2011-04-14 |
| CN1820025A (zh) | 2006-08-16 |
| JP2007528846A (ja) | 2007-10-18 |
| WO2005003166A1 (en) | 2005-01-13 |
| EP1639004B1 (en) | 2011-03-02 |
| NO332926B1 (no) | 2013-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SA521422068B1 (ar) | عوامل مساعدة لـ glp-1r واستخداماتها | |
| CR11042A (es) | Anticuerpos ox40 antagonistas y su uso en el tratamiento de enfermedades inflamatorias y autoinmunes | |
| NO20056055L (no) | Fluorescein-labelled peptides | |
| CL2009000349A1 (es) | Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer. | |
| NO20074824L (no) | Forlengelse av tid til sykdomsprogresjon eller overlevelse hos kreftpasienter | |
| CL2013003598A1 (es) | Compuestos derivados de benzooxazepinona, moduladores de canales de sodio; composición farmacéutica que los comprende; y su uso en el tratamiento de enfermedades seleccionadas de arritmias, insuficiencia cardiaca, angina, infarto al miocardio, diabetes, entre otras | |
| CO6710903A2 (es) | Un anticuerpo que reconoce y se une específicamente con un fosfo-epítope en la proteína tau de mamífero o en uno de sus fragmentos y una composición comprendiendo el mismo | |
| AR066987A1 (es) | Anticuerpo monoclonal contra proteina beta-amiloide | |
| GT201000148A (es) | Anticuerpos antimesotelina y usos de los mismos | |
| CY1115316T1 (el) | Πεπτιδια για τη θεραπευτικη αγωγη βητα-αμυλοειδωσεων | |
| EP1732602A4 (en) | CYTOTOXICITY TRANSFER OF CELLS WITH NOTES ON SURFACE EXPRESSION OF MCSP | |
| ATE526318T1 (de) | Farnesoid-x-rezeptor-agonisten | |
| NO20060230L (no) | Nye aminobenzofenonforbindelser | |
| NO20074036L (no) | Anvendelse av cyaninfargestoffer for diagnose av proliferative sykdommer | |
| CL2007000789A1 (es) | Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer. | |
| EA201100923A1 (ru) | Антитела человека против тканевого фактора | |
| EA201000207A1 (ru) | Новые иммуногенные эпитопы для иммунотерапии | |
| EA201101520A1 (ru) | Способы диагностики онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния | |
| EA200971130A1 (ru) | Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний | |
| UY29653A1 (es) | Nuevos anticuerpos anti-madcam | |
| EA201290964A1 (ru) | Пептидные конъюгаты агонистов рецептора glp-1 и их применение | |
| EA200900064A1 (ru) | Ингибирование агрегации альфа-синуклеина | |
| GB0718957D0 (en) | Optical imaging agents | |
| ATE538135T1 (de) | Verbindungen auf peptidbasis | |
| EA201490790A1 (ru) | Пептидные конъюгаты агониста рецептора гастрина и глюкагон подобного пептида 1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |